Literature DB >> 15207851

Downregulation of STAT3 activation is required for presumptive rod photoreceptor cells to differentiate in the postnatal retina.

Yoko Ozawa1, Keiko Nakao, Takuya Shimazaki, Junji Takeda, Shizuo Akira, Katsuhiko Ishihara, Toshio Hirano, Yoshihisa Oguchi, Hideyuki Okano.   

Abstract

Ciliary neurotrophic factor (CNTF) has been known to inhibit the differentiation of presumptive rod photoreceptor cells; however, the underlying mechanisms have remained to be elucidated. We demonstrated that STAT3 activation, but not SHP2 activation, is responsible for the CNTF/gp130 signaling that inhibits expression of Rhodopsin and its upstream activator, crx, in the retinal explants derived from P0 mice (P0 retinal explants), utilizing STAT3-deficient retina and electroporation of dominant-negative form of STAT3 (STAT3F). We also demonstrated that STAT3 activation in presumptive rod photoreceptor cells at E18.5 is rapidly downregulated at P0, when Rhodopsin expression starts during retinal development. Persistent STAT3 activation in the P0 retinal explants prevented Rhodopsin expression and rapid upregulation of crx expression. STAT3-deficient retinas did not exhibit precocious rod photoreceptor cell differentiation as a whole, although they occasionally exhibited precocious upregulation of crx mRNA. Thus, we conclude that downregulation of STAT3 activation is required, but insufficient, for rod photoreceptor cell differentiation in the postnatal retina. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207851     DOI: 10.1016/j.mcn.2004.02.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  17 in total

Review 1.  Studying rod photoreceptor development in zebrafish.

Authors:  A C Morris; J M Fadool
Journal:  Physiol Behav       Date:  2005-09-29

2.  Loss of Shp2-mediated mitogen-activated protein kinase signaling in Muller glial cells results in retinal degeneration.

Authors:  Zhigang Cai; David L Simons; Xin-Yuan Fu; Gen-Sheng Feng; Samuel M Wu; Xin Zhang
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

3.  OTX2 loss causes rod differentiation defect in CRX-associated congenital blindness.

Authors:  Jerome E Roger; Avinash Hiriyanna; Norimoto Gotoh; Hong Hao; Debbie F Cheng; Rinki Ratnapriya; Marie-Audrey I Kautzmann; Bo Chang; Anand Swaroop
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy.

Authors:  Karine Merienne; James Friedman; Masayuki Akimoto; Gretta Abou-Sleymane; Chantal Weber; Anand Swaroop; Yvon Trottier
Journal:  Neurobiol Dis       Date:  2006-12-26       Impact factor: 5.996

5.  Function and mechanism of CNTF/LIF signaling in retinogenesis.

Authors:  Kun Do Rhee; Xian-Jie Yang
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa.

Authors:  Kun Do Rhee; Alberto Ruiz; Jacque L Duncan; William W Hauswirth; Matthew M Lavail; Dean Bok; Xian-Jie Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

7.  Ciliary neurotrophic factor promotes muller glia differentiation from the postnatal retinal progenitor pool.

Authors:  Olivier Goureau; Kun Do Rhee; Xian-Jie Yang
Journal:  Dev Neurosci       Date:  2004       Impact factor: 2.984

8.  Specific protein kinase C isoforms are required for rod photoreceptor differentiation.

Authors:  Carolina Pinzon-Guzman; Samuel Shao-Min Zhang; Colin J Barnstable
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

9.  Pias3-dependent SUMOylation directs rod photoreceptor development.

Authors:  Akishi Onishi; Guang-Hua Peng; Chengda Hsu; Uel Alexis; Shiming Chen; Seth Blackshaw
Journal:  Neuron       Date:  2009-01-29       Impact factor: 17.173

10.  Regulation of posttranscriptional modification as a possible therapeutic approach for retinal neuroprotection.

Authors:  Yoko Ozawa; Toshihide Kurihara; Kazuo Tsubota; Hideyuki Okano
Journal:  J Ophthalmol       Date:  2010-11-07       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.